BeStock  
Markets › Compare › XNCR vs PVLA

XNCR vs PVLA

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
XNCR · Xencor$25.63 ▲ 3.18%
PVLA · Palvella Therapeutics$132.16 ▼ 0.23%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

77121165209253Oct 7, '25Apr 7, '26Oct 5, '26
  • XNCR +113.1%
  • PVLA +86.9%

Head to head

MetricXNCRPVLA
Price$25.63$132.16
Change today▲ 3.18%▼ 0.23%
Market cap$1.91B$1.90B
Return, 3 months+63.6%-9.3%
Return, year to date+67.4%+26.3%
Return, 1 year+117.4%+94.5%
P/E (TTM)-11.9-27.2
P/B3.88.8
P/E percentile vs own 5y12th–
Dividend yield––
Revenue growth (YoY, latest qtr)––
Net profit growth (YoY)––
Gross margin––
Operating margin––
Net margin––
Return on equity––
Analyst target vs. price+30.5%+78.0%
Analyst buy share91%100%
RSI (14)5633
30-day volatility52.7%37.5%
Max drawdown, 1 year-42.6%-31.1%
Trend readStrong uptrendLeaning bearish
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • XNCR is the largest of the group by market value.
  • XNCR has returned the most over the past year.
  • PVLA carries the lowest trailing P/E.
  • PVLA has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top